Physician profile
Brian Humphreys
NPI 1326088469
$2,294.13
in general payments reported to CMS, 2019-2025
19 companies · $394 in 2025
The $394 reported for 2025 was more than what a typical Plastic Surgery Within The Head & Neck provider received nationally (typical 2025 total: $238).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $162 · 2020: $19.38 · 2021: $641 · 2022: $480 · 2023: $438 · 2024: $159 · 2025: $394.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $893 · Education: $98.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $892.72 |
| Education | $98.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $692.61 | 2021-2025 | Inspire |
| Acclarent, INC | $350.70 | 2019-2023 | Acclarent Aera |
| Genzyme Corporation | $218.01 | 2022-2025 | |
| Stryker Corporation | $201.06 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $183.53 | 2021-2023 | |
| Regeneron Healthcare Solutions, INC. | $155.15 | 2023-2025 | Dupixent |
| Neurent Medical Limited | $87.07 | 2025 | Neuromark System, Neuromark Radiofrequency Console |
| Astrazeneca Pharmaceuticals LP | $84.05 | 2019 | |
| Glaxosmithkline, LLC. | $77.64 | 2025 | Nucala |
| Galderma Laboratories, L.P. | $37.96 | 2019-2024 | |
| Intersect Ent, INC. | $36.81 | 2019-2021 | |
| Olympus America INC. | $30.58 | 2021-2024 | Rhino-Laryngo Videoscope |
| Optinose US, INC. | $23.42 | 2021 | |
| Medtronic, INC. | $21.68 | 2024 | Stealthstation S8 Platform |
| Ars Pharmaceuticals Operations, INC. | $20.71 | 2025 | Neffy |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cochlear Americas | $19.97 | 2025 | Osia Osi300 Implant, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha |
| Davol INC. | $19.38 | 2020 | |
| Medtronic USA, INC. | $17.93 | 2019 | |
| Integra Lifesciences Corporation | $15.87 | 2025 | Acclarent Aera |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Humphreys listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.